NDC 13985-701 - MotaZol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-701
- Package NDCs from labels
- 13985-701-07, 13985-701-15, 13985-701-30, 13985-701-21
- Manufacturer
- MWI
- Effective date
- 2024-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MotaZol - MWI | MWI | 2024-11-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-701-07 | MotaZol | 7.5 g in 1 BOTTLE, DISPENSING | SUSPENSION | 7.5 | 7 | |
| 13985-701-07 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-15 | MotaZol | 15 g in 1 BOTTLE, DISPENSING | SUSPENSION | 15 | 7 | |
| 13985-701-15 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-21 | MotaZol | 215 g in 1 BOTTLE, PLASTIC | SUSPENSION | 215 | 7 | |
| 13985-701-21 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 30 g in 1 BOTTLE, DISPENSING | SUSPENSION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone Furoate Monohydrate | ACTIVE INGREDIENT | MTW0WEG809 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone | ACTIVE MOIETY | 8HR4QJ6DW8 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Clotrimazole 3 | CLOTRIMAZOLE | Walgreen Company | 7fafdebd-b117-4a6b-a499-a4d3ac086ab9 | 2025-07-08 | Warnings | G07GZ97H65 |
| Clotrimazole 1% Athletes Foot | CLOTRIMAZOLE | STRATEGIC SOURCING SERVICES LLC | 9aba1345-ef47-4951-8448-a43d6696b616 | 2025-07-07 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | e4e9f244-4a85-4c0d-9917-93182c4a6e87 | 2025-07-07 | Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | 3e2041a0-8bef-4be4-b2b1-556446c4a778 | 2025-07-03 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | a3a5cbf5-cabb-48d8-8877-74a97f7c0f57 | 2025-07-03 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | 325a40b0-3e17-47c6-8988-d5396ca5d53f | 2025-07-02 | Warnings | G07GZ97H65 |
| meijer Athletes Foot | CLOTRIMAZOLE | Meijer Distribution Inc | fdb15cd8-6726-4150-9b9d-6ef3ee01a5d2 | 2025-07-02 | Warnings | G07GZ97H65 |
| Rexall Jock Itch | CLOTRIMAZOLE | Dollar General | 11427a79-f262-4702-9b2e-ec1955a9b2da | 2025-07-02 | Warnings | G07GZ97H65 |
| Rexall Athletes Foot | CLOTRIMAZOLE | Dollar General | 664579a1-a5b0-4a4c-bff6-4347f3e1d3bb | 2025-07-02 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Granules Pharmaceuticals Inc. | 1280353c-9f96-557e-e063-6294a90a10f9 | 2025-06-30 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | f7192955-8f8c-45dd-a215-8ac2c1f6444f | 2025-06-12 | Warnings | G07GZ97H65 |
| Terrasil Anti-Fungal Treatment MAX | CLOTRIMAZOLE | Aidance Scientific, Inc., DBA Aidance Skincare & Topical Solutions | db356cc8-f473-4eb2-b8d8-72606fca9dc0 | 2025-05-23 | Warnings | G07GZ97H65 |
| terrasil Folliculitis Cream Maximum Strength | CLOTRIMAZOLE | Aidance Scientific, Inc., DBA Aidance Skincare & Topical Solutions | 35d54756-00dd-bbe1-e063-6394a90a9e02 | 2025-05-23 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole | CLOTRIMAZOLE | Cardinal Health (Leader) 70000 | 4aaae616-179b-40f1-8a39-6a1ddd414070 | 2025-04-29 | Warnings | G07GZ97H65 |
| ANTIFUNGAL | CLOTRIMAZOLE | VIVE HEALTH LLC | 33db98f5-f6d9-742a-e063-6394a90a2a03 | 2025-04-28 | Warnings | G07GZ97H65 |
| Clotrimazole 1% Athletes Foot | CLOTRIMAZOLE | GERI-GENTLE CORPORATION | e673748f-d00b-4ce8-e053-2995a90a9220 | 2025-04-21 | Warnings | G07GZ97H65 |
| CLOTRIMAZOLE | CLOTRIMAZOLE | Rising Pharma Holdings, Inc. | 980736aa-751a-4642-ab85-a309435fd02f | 2025-03-27 | Warnings, Adverse reactions | G07GZ97H65 |
| Forticept Antifungal Foot Gel | CLOTRIMAZOLE | Lidan, Inc. | 1b5851fc-ae73-4e54-bb62-3ff928628b97 | 2025-03-25 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.